EBX endura

ESG: One procedure. Sustainable weight loss for your patients.

With lifestyle changes, ESG provides a clinically proven, minimally invasive endoscopic option for weight loss.

Introducing Endoscopic Sleeve Gastroplasty (ESG)

The IFSO Bariatric Endoscopy Committee endorses Endoscopic Sleeve Gastroplasty (ESG) as an effective and valuable treatment for obesity.1

ESG is a minimally invasive endoscopic bariatric procedure designed to support gradual, lasting weight loss when combined with lifestyle changes.

It is particularly beneficial for patients with class I and II obesity, as well as for those with class III obesity who are not suitable candidates for metabolic bariatric surgery.1

No incisions or scars

Typically a same-day procedure

Organ-sparing and revisable

Preserves future treatment options

ESG Procedure Overview

AttributeDescription
Procedure typeEndoscopic bariatric procedure
Access routeTransoral
MechanismGastric volume reduction via suturing
Clinical goal

Weight loss support in patients with Class I, II, and selected Class III obesity

How the ESG Procedure is Performed

ESG reduces stomach size using sutures placed through the mouth during a simple outpatient procedure. It is performed under general anaesthesia by a trained gastroenterologist or surgeon that uses the OverStitch NXT™ Endoscopic Suturing System to create 6-8 plications along the greater curve of the stomach.

Step-by-Step Procedure Overview

1. A flexible endoscope is introduced transorally into the stomach

2. The OverStitch NXT™ Endoscopic Suturing System is deployed to place endoscopic sutures

3. 6-8 plications are created along the greater curvature

4. Gastric volume is reduced by approximately 70-80%, promoting early satiety and supporting sustained weight loss when combined with diet and lifestyle modifications

Curious to learn more about the ESG procedure? Here’s how it works:

Sustainable Results

~70-80% stomach capacity reduction

ESG helps people living with obesity eat less, feel fuller faster, and achieve significant, lasting weight loss when combined with lifestyle changes.

Proven weight loss that lasts

In the MERIT randomised clinical trial, ESG patients lost an average of 13.6% of total body weight at year 1.²

Minimal time away

Most patients typically go home the same day as the procedure and can return to routine daily activity in 2-3 days.²

Clinical Evidence

Download our leaflet for a concise, evidence-based overview of ESG, showcasing the latest clinical data and insights that support its safety and efficacy.

Clinical Evidence in Primary Procedures

Filename
esg-clinical-leaflet.pdf
Size
1 MB
Format
application/pdf
Download

     

SourcePopulationKey Outcome
MERIT RCT2Class II-III obesity13.6% mean total body weight loss at 1 year 
IFSO Endorsement1Class I-III obesityEndorsed as effective and valuable treatment 

Key Resources

ESG Procedure

ESG Physician Brochure

Filename
ESG-Physician-Brochure.pdf
Size
3 MB
Format
application/pdf
Download

Adopting ESG – Interview with Dr. Lubbe

Dr. Lubbe shares what led her to adopt the endoscopic approach in her bariatric department, with a focus on the role of ESG.

Resources for Patients

Discover comprehensive resources tailored for ESG patients across the UK, Italy, Germany, Spain, and France.

Patient Perspective: Joanna’s ESG Journey

Listen to Joanna’s story as she shares her transformative weight loss journey with ESG.

Endoscopic Sleeve Gastroplasty (ESG) for patients in the UK

Gastroplastica endoscopica per i pazienti in Italia

Endoskopische Schlauchmagen für Patienten in Deutschland

Gastroplastia endoscópica en manga para pacientes en España

Sleeve gastroplastie endoscopique pour les patients en France

   

Explore Other Endoscopic Bariatric Procedures

IGBs

Intragastric Balloons (IGBs)

A non-surgical, temporary option to support weight loss in patients with obesity. IGBs are placed endoscopically and work by reducing stomach capacity to promote early satiety.

Learn about IGBs

TORe

Transoral Outlet Reduction (TORe)

An endoscopic procedure designed to address weight regain following Roux-en-Y gastric bypass, by reducing the size of the gastrojejunal anastomosis.

Learn about TORe

Alternative Bariatric Procedures

  • Laparoscopic sleeve gastrectomy (LSG), also referred to as vertical sleeve gastrectomy, is a restrictive bariatric procedure predominantly performed via laparoscopy. During LSG, approximately 75-85% of the stomach is resected along the greater curvature. This procedure induces significant neurohormonal and bile signaling modifications, contributing to its metabolic efficacy.3
  • Roux-en-Y gastric bypass (RYGB) involves the exclusion of a portion of the stomach and proximal intestine, with the distal intestine reconfigured into a Y-configuration. This allows for the passage of ingested food from the upper gastric pouch through the Roux limb, facilitating both weight loss and metabolic benefits, independent of weight reduction.3

 

One Partner. Multiple Solutions.

At Boston Scientific, we deliver services and solutions designed to support professional education, operational efficiency and environmental sustainability.

Connect with us:

Connect with our team to access the support, resources, and information you need to stay informed and make the most of our endoscopy solutions.

1. IFSO (International Federation for the Surgery of Obesity and Metabolic Disorders) Bariatric Endoscopy Committee Evidence‑Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management. 2024.
2. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al; MERIT Study Group. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 20226;400(10350):441-51.
3. IFSO-WGO GUIDELINES ON OBESITY CONTENTS. 2022.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material is not intended for use in France.